ProQR Therapeutics (PRQR) Deferred Taxes (2020 - 2024)

ProQR Therapeutics (PRQR) has reported Deferred Taxes for 5 consecutive years, with -$227590.9 the latest figure, recorded in Q2 2024.

• Quarterly Deferred Taxes changed N/A year-over-year to -$227590.9 in Q2 2024, while the trailing twelve-month figure through Sep 2024 was -$318627.2 (down 2253.85% YoY) and the FY2021 annual result came in at $133140.6, down 5.65% from the prior year.
• Deferred Taxes declined to -$227590.9 in Q2 2024 per PRQR's latest filing, from $3413.9 in the prior quarter.
• Over the last five years, Deferred Taxes for PRQR reached as high as $85346.6 in Q3 2020 and fell as low as -$227590.9 in Q2 2024.
• A 5-year average of $4989.5 and a median of $22759.1 in 2022 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2021 — Deferred Taxes surged 381.82% — and 2023, when it slumped 220.29%.
• Year by year, Deferred Taxes stood at $43242.3 in 2020, then plunged by 42.11% to $25035.0 in 2021, then surged by 213.64% to $78518.8 in 2022, then sank by 220.29% to -$94450.2 in 2023, then sank by 140.96% to -$227590.9 in 2024.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$227590.9, $3413.9, and -$94450.2 for Q2 2024, Q1 2024, and Q3 2023 respectively.